ODDB.org: Open Drug Database

Home - 68795 - 02 - 002

Rivastigmin-Mepha Patch 9.5 mg/24 h, Transdermale Pflaster - 30

Swissmedic Key	68795002	Registration Holder	Mepha Pharma AG
Name	Rivastigmin-Mepha Patch 9.5 mg/24 h, Transdermale Pflaster	Date of registration	15.11.2022
Original/Generic	Generic	Introduction of Sequence	15.11.2022
ATC-Classification	Rivastigmine (N06DA03)	Revision date
WHO	WHO-DDD	Valid until	14.11.2027
Index Therapeuticus (BSV)	01.99.	Show package size	30
Index Therapeuticus (Swissmedic)	01.99.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	39.51	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	61.80
Feedback	FB	Daily cost
GTIN	7680687950022	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

rivastigminum 12.8 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, Trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 8.5 cm², cum liberatione 9.5 mg/24h.

Packungsbestandteile

Galenic Form

Transdermale Pflaster

Active Agent	Dose
Rivastigmine	12.8 mg

BAG: Active Agent	Dose
Rivastigmine	12.8 mg

Inactive agents	Dose	additional_information
2-ethylhexylis Acrylatis
Ad Praeparationem	8.5 cm
Cum Liberatione	9.5mg / 24h
Paraffine Perliquide
Polyesterum
Polyethylenum/aluminium Polyesterum		Trägermaterial
Polyisobutylenum
Silica Colloidalis Anhydrica
Vinylis Acetatis Polymerisatum

Source

Data was imported : 07.12.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2024	©ywesee GmbH